Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

237.93
Delayed Data
As of Aug 26
 +1.62 / +0.69%
Today’s Change
195.50
Today|||52-Week Range
322.68
-23.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Operating ActivitiesNet Income / Starting Line5.3B-629.3M256.4M-499.9M
 
 
 
 
 
Depreciation1.2B1.6B1.6B1.7B
 
 
 
 
 
Total Other Cash Flow1.2B696.5M204.8M429.3M
 
 
 
 
 
Funds From Operations896.1M1.8B1.6B1.8B
 
 
 
 
 
Funds From/For Other Operating Expenses-152.1M219.2M357.7M402.4M
 
 
 
 
 
Net Cash Flow - Operating Activities1.0B1.6B1.2B1.4B
 
 
 
 
 
 
InvestingIncrease In Investments-6.0M2.7M0.000.00
 
 
 
Decrease In Investments0.00883.0M19.0M6.5M
 
 
 
 
Capital Expenditures-102.5M-104.2M-84.9M-97.9M
 
 
 
 
 
Fixed Asset Disposal52.1M6.5M12.1M2.4M
 
 
 
 
 
Net Assets From Acquisitions -132.8M-2.3B0.000.00
 
 
 
Net Cash Flow Investing-251.8M-2.4B-53.8M-89.0M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings0.00799.3M900.0M0.00
 
 
 
Long Term Debt Reduction-230.5M-807.5M-854.2M-3.0B
 
 
 
 
 
Net Proceeds Stock Sale87.6M34.2M69.6M37.7M
 
 
 
 
 
Common Preferred Redeemed-7.2M-9.8M-53.2M-14.1M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-69.7M-69.7M-69.6M-69.6M
 
 
 
 
 
Other Sources - Financing17.7M22.1M34.6M-2.7M
 
 
 
 
 
Other Uses - Financing46.3M91.8M32.3M31.5M
 
 
 
 
 
Net Cash Flow - Financing-248.4M-123.2M-5.1M-3.1B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-2.0M-1.4M5.2M-3.2M
 
 
 
 
 
 
Net Change In Cash548.0M-966.5M1.2B-1.8B